This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics

SAVINGS DEADLINE EXPIRES:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Delivered as Hybrid Event from 16-18 November 2022
Live In-Person Conference Delivered 16-18 NovemberAustria Center Vienna

J. William Efcavitch, PhD
Co-Founder & Chief Scientific Officer at Molecular Assemblies

Profile

Bill Efcavitch was the ninth employees at Applied Biosystems. He built and managed the research and development groups that led the commercialization of phosphoramidite oligonucleotide synthesis and the Model 380A, 380B and 381 DNA synthesizers. During his 23 years at Applied Biosystems, he managed the development of many successful biotechnology instrument and reagent systems, including the ABI 1700 Expression Array System, Model 3900 DNA Synthesizer, ABI Prism Models 377 and 3700 Genetic Analyzers, ABI Model 310 DNA Analyzer, and the Model 230A Micro Preparative Electrophoresis System. He is co-inventor of the flowable polymer for capillary electrophoresis DNA sequencing used in all Applied Biosystems’ capillary sequencers as well as virtual terminator nucleotides for single molecule DNA sequencing. 

At Helicos BioSciences, he led the development of the Helicos® Genetic Analysis System, the world’s first commercially available single molecule DNA sequencer. Dr. Efcavitch has also served as an independent consultant to several venture capital firms and biotechnology start-up companies. 

Dr. Efcavitch received his PhD in 1978 at Ohio University, where he studied with Dr. Thomas E. Wagner. He was also a post-doctoral fellow with Dr. Marvin H. Caruthers at the University of Colorado in Boulder from 1978-1981, before joining Applied Biosystems.

Agenda Sessions

  • Breaking the Barrier to Long, High Purity Synthetic DNA

    15:00